Abstract
Abnormal production of inflammatory mediators is believed to play an important role in the pathogenesis of psoriasis. Emerging data, both in mice and in humans, put the spotlight on a new subset of T helper (Th) cells, in part characterized by their production of IL-17 and accordingly named Th17 cells. Here, we review the development, characterization, and function of human Th17 cells as well as the crucial role of IL-23 in the context of Th17-cell-dependent chronic inflammation in psoriasis. We further discuss recent clinical trials targeting the IL-23/Th17 axis in psoriasis. Journal of Investigative Dermatology (2009) 129, 1339-1350; doi:10.1038/jid.2009.59; published online 26 March 2009
Original language | English |
---|---|
Pages (from-to) | 1339 - 1350 |
Number of pages | 12 |
Journal | Journal of Investigative Dermatology |
Volume | 129 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2009 |